{"transactions":[{"id":727471,"issuer":{"id":756,"kind":"organization","name":"CAVA GROUP, INC.","symbol":"CAVA"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-24T20:01:19.000Z","date":"2026-06-22","kind":"grant","planned":false,"acquired":true,"shares":1881,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units (\"RSUs\"), which vest in full on the earlier of (i) June 22, 2027 and (ii) the business day before the date of the next annual meeting of the stockholders of CAVA Group Inc. (the \"Issuer\"), subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 per share upon settlement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":19955,"source":{"system":"sec-edgar","filing":"0001628280-26-045156","document":"wk-form4_1782331276.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376854/000162828026045156/wk-form4_1782331276.xml","form_type":"4"}},{"id":750066,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-06-04T20:10:52.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":false,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":89312},"source":{"system":"sec-edgar","filing":"0001062822-26-000103","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000103/form4.xml","form_type":"4"}},{"id":750065,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-06-04T20:10:52.000Z","date":"2026-06-03","kind":"exercise","planned":false,"acquired":true,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":374486,"source":{"system":"sec-edgar","filing":"0001062822-26-000103","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000103/form4.xml","form_type":"4"}},{"id":794411,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-04T20:59:21.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":43478,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":43478,"derivative":{"exercise_price":1.61,"expiration_date":"2036-05-01","underlying":"Common Stock","underlying_shares":43478},"source":{"system":"sec-edgar","filing":"0001062822-26-000092","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000092/form4.xml","form_type":"4"}},{"id":794410,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2026-05-04T20:59:21.000Z","date":"2026-05-01","kind":"grant","planned":false,"acquired":true,"shares":35714,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":35714,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":35714},"source":{"system":"sec-edgar","filing":"0001062822-26-000092","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000106282226000092/form4.xml","form_type":"4"}},{"id":1102477,"issuer":{"id":756,"kind":"organization","name":"CAVA GROUP, INC.","symbol":"CAVA"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-24T21:23:20.000Z","date":"2025-06-20","kind":"grant","planned":false,"acquired":true,"shares":1767,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units (\"RSU\"), which vest in full on the earlier of (i) June 20, 2026 and (ii) the business day before the date of the next annual meeting of the stockholders of CAVA Group Inc. (the \"Issuer\"), subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 per share upon settlement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":18074,"source":{"system":"sec-edgar","filing":"0001628280-25-032885","document":"wk-form4_1750800194.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376854/000162828025032885/wk-form4_1750800194.xml","form_type":"4"}},{"id":1125930,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-06-03T20:21:00.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":89312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":89312,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":89312},"source":{"system":"sec-edgar","filing":"0001127602-25-016461","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225016461/form4.xml","form_type":"4"}},{"id":1125929,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-03T20:21:00.000Z","date":"2025-06-03","kind":"grant","planned":false,"acquired":true,"shares":103806,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":103806,"derivative":{"exercise_price":0.6216,"expiration_date":"2035-06-03","underlying":"Common Stock","underlying_shares":103806},"source":{"system":"sec-edgar","filing":"0001127602-25-016461","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225016461/form4.xml","form_type":"4"}},{"id":1151238,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2025-05-13T21:49:27.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":false,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":36810},"source":{"system":"sec-edgar","filing":"0001127602-25-014140","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225014140/form4.xml","form_type":"4"}},{"id":1151237,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2025-05-13T21:49:27.000Z","date":"2025-05-13","kind":"exercise","planned":false,"acquired":true,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":285174,"source":{"system":"sec-edgar","filing":"0001127602-25-014140","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760225014140/form4.xml","form_type":"4"}},{"id":1470425,"issuer":{"id":756,"kind":"organization","name":"CAVA GROUP, INC.","symbol":"CAVA"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-24T20:05:30.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":1307,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units (\"RSU\"), which vest in full on the earlier of (i) June 20, 2025 and (ii) the business day before the date of the next annual meeting of the stockholders of CAVA Group Inc. (the \"Issuer\"), subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 per share upon settlement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":16307,"source":{"system":"sec-edgar","filing":"0001628280-24-029569","document":"wk-form4_1719259522.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376854/000162828024029569/wk-form4_1719259522.xml","form_type":"4"}},{"id":1519502,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-05-13T20:00:44.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":36810,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":36810,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":36810},"source":{"system":"sec-edgar","filing":"0001127602-24-015076","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224015076/form4.xml","form_type":"4"}},{"id":1519501,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-13T20:00:44.000Z","date":"2024-05-13","kind":"grant","planned":false,"acquired":true,"shares":44906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":44906,"derivative":{"exercise_price":1.79,"expiration_date":"2034-05-13","underlying":"Common Stock","underlying_shares":44906},"source":{"system":"sec-edgar","filing":"0001127602-24-015076","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224015076/form4.xml","form_type":"4"}},{"id":1534025,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2024-04-29T20:16:09.000Z","date":"2024-04-28","kind":"exercise","planned":false,"acquired":false,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8032},"source":{"system":"sec-edgar","filing":"0001127602-24-013553","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224013553/form4.xml","form_type":"4"}},{"id":1534024,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2024-04-29T20:16:09.000Z","date":"2024-04-28","kind":"exercise","planned":false,"acquired":true,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":248364,"source":{"system":"sec-edgar","filing":"0001127602-24-013553","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760224013553/form4.xml","form_type":"4"}},{"id":1732364,"issuer":{"id":756,"kind":"organization","name":"CAVA GROUP, INC.","symbol":"CAVA"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-11-21T21:00:58.000Z","date":"2023-11-17","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":33.18,"value":331800.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $33.13 to $33.21 per share, inclusive. The reporting person undertakes to provide to CAVA Group, Inc., any security holder of CAVA Group, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested restricted stock units."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0001628280-23-039763","document":"wk-form4_1700600447.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376854/000162828023039763/wk-form4_1700600447.xml","form_type":"4"}},{"id":1742778,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-11-14T21:12:48.000Z","date":"2023-11-13","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":1.0076,"value":201520.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $0.9858 to $1.0400 per share. The price reported above reflects the weighted average purchase price of such trades. Mr. Amouyal hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which this transaction was effected."}],"balance_after":240332,"source":{"system":"sec-edgar","filing":"0001127602-23-027360","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223027360/form4.xml","form_type":"4"}},{"id":1846236,"issuer":{"id":756,"kind":"organization","name":"CAVA GROUP, INC.","symbol":"CAVA"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-22T20:36:54.000Z","date":"2023-06-20","kind":"grant","planned":false,"acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Reflects a grant of restricted stock units (\"RSU\"), which vest in full on the earlier of (i) June 14, 2024 and  (ii) the business day before the date of the next annual meeting of the stockholders of CAVA Group, Inc. (the \"Issuer\"), subject to the reporting person's continued service through such date. Each RSU represents a contingent right to receive one share of the Issuer's common stock, par value $0.0001 per share upon settlement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes unvested RSUs."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001628280-23-023150","document":"wk-form4_1687466203.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376854/000162828023023150/wk-form4_1687466203.xml","form_type":"4"}},{"id":1883112,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-05-22T20:01:46.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":false,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-23-016428","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016428/form4.xml","form_type":"4"}},{"id":1883111,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2023-05-22T20:01:46.000Z","date":"2023-05-21","kind":"exercise","planned":false,"acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":40332,"source":{"system":"sec-edgar","filing":"0001127602-23-016428","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223016428/form4.xml","form_type":"4"}},{"id":1911571,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2023-04-28T20:21:01.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":12658,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":12658,"derivative":{"exercise_price":2.36,"expiration_date":"2033-04-28","underlying":"Common Stock","underlying_shares":12658},"source":{"system":"sec-edgar","filing":"0001127602-23-013780","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013780/form4.xml","form_type":"4"}},{"id":1911570,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2023-04-28T20:21:01.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":8032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":8032,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":8032},"source":{"system":"sec-edgar","filing":"0001127602-23-013780","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760223013780/form4.xml","form_type":"4"}},{"id":2260522,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-23T20:12:20.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":9302,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":9302,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9302},"source":{"system":"sec-edgar","filing":"0001127602-22-015365","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015365/form4.xml","form_type":"4"}},{"id":2260521,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-23T20:12:20.000Z","date":"2022-05-21","kind":"grant","acquired":true,"shares":14402,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":14402,"derivative":{"exercise_price":1.77,"expiration_date":"2032-05-21","underlying":"Common Stock","underlying_shares":14402},"source":{"system":"sec-edgar","filing":"0001127602-22-015365","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222015365/form4.xml","form_type":"4"}},{"id":2286812,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2022-05-02T20:11:58.000Z","date":"2022-04-30","kind":"exercise","acquired":false,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-22-012824","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012824/form4.xml","form_type":"4"}},{"id":2286811,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2022-05-02T20:11:58.000Z","date":"2022-04-30","kind":"exercise","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":31030,"source":{"system":"sec-edgar","filing":"0001127602-22-012824","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760222012824/form4.xml","form_type":"4"}},{"id":2733355,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2021-05-03T21:02:18.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":6475,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":6475,"derivative":{"exercise_price":5.04,"expiration_date":"2031-04-30","underlying":"Common Stock","underlying_shares":6475},"source":{"system":"sec-edgar","filing":"0001127602-21-014960","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014960/form4.xml","form_type":"4"}},{"id":2733354,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-05-03T21:02:18.000Z","date":"2021-04-30","kind":"grant","acquired":true,"shares":4024,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":4024,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":4024},"source":{"system":"sec-edgar","filing":"0001127602-21-014960","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014960/form4.xml","form_type":"4"}},{"id":2738784,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2021-04-27T20:45:32.000Z","date":"2021-04-24","kind":"exercise","acquired":false,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-21-014517","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014517/form4.xml","form_type":"4"}},{"id":2738783,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2021-04-27T20:45:32.000Z","date":"2021-04-24","kind":"exercise","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":27006,"source":{"system":"sec-edgar","filing":"0001127602-21-014517","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760221014517/form4.xml","form_type":"4"}},{"id":3169346,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:43:59.000Z","date":"2020-04-26","kind":"exercise","acquired":false,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001127602-20-014560","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014560/form4.xml","form_type":"4"}},{"id":3169345,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2020-04-27T20:43:59.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":10638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":10638,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":10638},"source":{"system":"sec-edgar","filing":"0001127602-20-014560","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014560/form4.xml","form_type":"4"}},{"id":3169344,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2020-04-27T20:43:59.000Z","date":"2020-04-24","kind":"grant","acquired":true,"shares":18115,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":18115,"derivative":{"exercise_price":1.86,"expiration_date":"2030-04-24","underlying":"Common Stock","underlying_shares":18115},"source":{"system":"sec-edgar","filing":"0001127602-20-014560","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014560/form4.xml","form_type":"4"}},{"id":3169343,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2020-04-27T20:43:59.000Z","date":"2020-04-26","kind":"exercise","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":16368,"source":{"system":"sec-edgar","filing":"0001127602-20-014560","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760220014560/form4.xml","form_type":"4"}},{"id":3546821,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Restricted Stock Units","published_at":"2019-04-29T21:07:50.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":3466,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."}],"balance_after":3466,"derivative":{"underlying":"Common Stock","underlying_shares":3466},"source":{"system":"sec-edgar","filing":"0001127602-19-016496","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219016496/form4.xml","form_type":"4"}},{"id":3546820,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2019-04-29T21:07:50.000Z","date":"2019-04-26","kind":"grant","acquired":true,"shares":6519,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date."}],"balance_after":6519,"derivative":{"exercise_price":5.67,"expiration_date":"2029-04-26","underlying":"Common Stock","underlying_shares":6519},"source":{"system":"sec-edgar","filing":"0001127602-19-016496","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760219016496/form4.xml","form_type":"4"}},{"id":3706570,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T21:09:57.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":453,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":47484,"source":{"system":"sec-edgar","filing":"0001209191-19-001885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919119001885/doc4.xml","form_type":"4"}},{"id":3800000,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-03T20:10:32.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":262,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":47031,"source":{"system":"sec-edgar","filing":"0001209191-18-053770","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118053770/doc4.xml","form_type":"4"}},{"id":3828114,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-04T20:54:02.000Z","date":"2018-08-31","kind":"sale","acquired":false,"shares":7500,"price":75.5854,"value":566890.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $75.58 to $75.61, inclusive. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":46769,"source":{"system":"sec-edgar","filing":"0001209191-18-049233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118049233/doc4.xml","form_type":"4"}},{"id":3828113,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-09-04T20:54:02.000Z","date":"2018-08-31","kind":"gift","acquired":false,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":54269,"source":{"system":"sec-edgar","filing":"0001209191-18-049233","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118049233/doc4.xml","form_type":"4"}},{"id":3873596,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T20:14:04.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":187,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":61769,"source":{"system":"sec-edgar","filing":"0001209191-18-041575","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118041575/doc4.xml","form_type":"4"}},{"id":3955195,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2018-04-27T21:35:07.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant."}],"balance_after":2857,"derivative":{"exercise_price":7.8,"expiration_date":"2028-04-27","underlying":"Common Stock","underlying_shares":2857},"source":{"system":"sec-edgar","filing":"0001127602-18-015439","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218015439/form4.xml","form_type":"4"}},{"id":3955194,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2018-04-27T21:35:07.000Z","date":"2018-04-27","kind":"grant","acquired":true,"shares":2564,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12902,"source":{"system":"sec-edgar","filing":"0001127602-18-015439","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760218015439/form4.xml","form_type":"4"}},{"id":3957907,"issuer":{"id":167336,"kind":"organization","name":"Blue Buffalo Pet Products, Inc.","symbol":"BUFF"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-24T20:54:54.000Z","date":"2018-04-24","kind":"disposition_to_issuer","acquired":false,"shares":10569,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 24, 2018, General Mills, Inc., a Delaware corporation (\"Buyer\"), acquired the Issuer pursuant to that certain Agreement and Plan of Merger entered into by and among the Issuer, Buyer and Bravo Merger Corp., a Delaware corporation and wholly-owned subsidiary of Buyer (\"Merger Sub\"), dated as of February 22, 2018 (the \"Merger Agreement\"). In accordance with the Merger Agreement, Merger Sub merged with and into the Issuer, with the Issuer surviving such merger as a wholly-owned subsidiary of Buyer (the \"Merger\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"At the effective time of the Merger, each outstanding share of the Issuer's common stock (other than certain excluded shares) automatically converted into the right to receive $40.00 in cash, without interest and after giving effect to any required withholding taxes."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-18-010667","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376854/000089924318010667/doc4.xml","form_type":"4"}},{"id":3971280,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-04T20:25:43.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":61582,"source":{"system":"sec-edgar","filing":"0001209191-18-023647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118023647/doc4.xml","form_type":"4"}},{"id":4109574,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T21:15:48.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":390,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":61287,"source":{"system":"sec-edgar","filing":"0001209191-18-001918","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919118001918/doc4.xml","form_type":"4"}},{"id":4193235,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-04T20:46:19.000Z","date":"2017-10-02","kind":"grant","acquired":true,"shares":435,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":60897,"source":{"system":"sec-edgar","filing":"0001209191-17-055897","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117055897/doc4.xml","form_type":"4"}},{"id":4262921,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-06T20:03:55.000Z","date":"2017-07-03","kind":"grant","acquired":true,"shares":569,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":60462,"source":{"system":"sec-edgar","filing":"0001209191-17-043968","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117043968/doc4.xml","form_type":"4"}},{"id":4340647,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-01T20:47:57.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":2857,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option vests with respect to 1/12th of the shares subject to the option for each month of service following the date of grant."}],"balance_after":2857,"derivative":{"exercise_price":15.61,"expiration_date":"2027-04-28","underlying":"Common Stock","underlying_shares":2857},"source":{"system":"sec-edgar","filing":"0001127602-17-016054","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217016054/form4.xml","form_type":"4"}},{"id":4340646,"issuer":{"id":4970,"kind":"organization","name":"LEXICON PHARMACEUTICALS, INC."},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true}}],"security":"Common Stock","published_at":"2017-05-01T20:47:57.000Z","date":"2017-04-28","kind":"grant","acquired":true,"shares":1281,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10338,"source":{"system":"sec-edgar","filing":"0001127602-17-016054","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1062822/000112760217016054/form4.xml","form_type":"4"}},{"id":4359395,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-05T20:08:42.000Z","date":"2017-04-03","kind":"grant","acquired":true,"shares":1216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":59893,"source":{"system":"sec-edgar","filing":"0001209191-17-025584","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117025584/doc4.xml","form_type":"4"}},{"id":4360089,"issuer":{"id":167336,"kind":"organization","name":"Blue Buffalo Pet Products, Inc.","symbol":"BUFF"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-04-04T20:31:46.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":3695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a grant of restricted stock that is fully vested."}],"balance_after":10569,"source":{"system":"sec-edgar","filing":"0000899243-17-009257","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376854/000089924317009257/doc4.xml","form_type":"4"}},{"id":4500587,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-01-05T21:13:33.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":58677,"source":{"system":"sec-edgar","filing":"0001209191-17-002007","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919117002007/doc4.xml","form_type":"4"}},{"id":4518005,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-12-19T21:06:35.000Z","date":"2016-12-15","kind":"grant","acquired":true,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":57873,"source":{"system":"sec-edgar","filing":"0001209191-16-155875","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919116155875/doc4.xml","form_type":"4"}},{"id":4585647,"issuer":{"id":6479,"kind":"organization","name":"WW INTERNATIONAL, INC.","symbol":"WW"},"owners":[{"id":35613,"kind":"person","name":"Amouyal Philippe","position":1,"cik":"0001376854","reported_name":"Amouyal Philippe","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2016-10-05T20:14:14.000Z","date":"2016-10-03","kind":"grant","acquired":true,"shares":904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares listed represent shares of Common Stock subject to transfer restrictions."}],"balance_after":56873,"source":{"system":"sec-edgar","filing":"0001209191-16-144892","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105319/000120919116144892/doc4.xml","form_type":"4"}}]}